India  

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Video Credit: Wochit News - Duration: 00:35s - Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies.

The FDA officially announced the medicine could be used in treating COVID-19 patients.

Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals.

Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients.

It could shorten satsy by several days, reports Gizmodo.

0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Gilead Sciences Gilead Sciences American pharmaceutical company

Gilead's remdesivir gets conditional EU clearance [Video]

Gilead's remdesivir gets conditional EU clearance

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.

Credit: Reuters Studio    Duration: 00:59Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published
Stocks rise on recovery hopes [Video]

Stocks rise on recovery hopes

U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:22Published
EU close to fast-tracking COVID-19 treatment drug [Video]

EU close to fast-tracking COVID-19 treatment drug

The head of the European Union's medicines agency, Guido Rasi, has said an initial authorization for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days. Joe Davies reports.

Credit: Reuters Studio    Duration: 01:40Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Karnataka private hospitals refusing to admit COVID patients to face criminal case [Video]

Karnataka private hospitals refusing to admit COVID patients to face criminal case

Karnataka Medical Education Minister Dr K Sudhakar on July 05 stated that criminal case will be filed against those private hospitals that refuse to admit COVID-19 patients. Meanwhile, the total number of COVID-19 cases in Karnataka has reached 21,549.

Credit: ANI    Duration: 01:27Published
COVID: Mathura's famous 'Guru Purnima' fair called off [Video]

COVID: Mathura's famous 'Guru Purnima' fair called off

For the first time in years, Mathura's famous Guru Purnima Fair has been cancelled due to COVID crisis. Temples in Mathura wore a deserted look. All shrines across country were shut to control the pace of coronavirus spread. Thousands of devotees, from all parts of country used to attend 'Mudia Mela'.

Credit: ANI    Duration: 01:08Published

COVID-19: Lockdown to be eased in Chennai from Monday

Earlier, the state government announced a 12-hour strict lockdown in four cities on June 19 in Tiruvallur, Chennai, Kancheepuram, and Chengalpattu.Currently, the..
DNA

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

Former FDA head says 'exponential' rise in COVID-19 possible [Video]

Former FDA head says 'exponential' rise in COVID-19 possible

Former Food and Drug Administration Commissioner Scott Gottlieb on Sunday warned that some U.S. states, including Texas, Florida and Arizona, could start to see an 'exponential' rise in COVID-19 cases this coming week. This report produced by Yahaira Jacquez.

Credit: Reuters - Politics    Duration: 01:40Published
Gottlieb warns of 'exponential' rise in COVID-19 cases in some U.S. states [Video]

Gottlieb warns of 'exponential' rise in COVID-19 cases in some U.S. states

Former Food and Drug Administration Commissioner Scott Gottlieb on Sunday warned that some U.S. states, including Texas, Florida and Arizona, could start to see an 'exponential' rise in COVID-19 cases this coming week. This report produced by Yahaira Jacquez.

Credit: Reuters Studio    Duration: 01:40Published

Gizmodo Gizmodo Design, technology, science, and science fiction website and blog

Children Experiencing Frightening After-Effects From Syndrome Connected To COVID-19 [Video]

Children Experiencing Frightening After-Effects From Syndrome Connected To COVID-19

Frightening neurological complications can happen in children who develop a mysterious condition linked to the novel coronavirus COVID-19. A new study says survivors can suffer headaches and muscle weakness, along with visible signs of damage to the brain. According to Gizmodo, the condition is commonly known as multisystem inflammatory syndrome in children, or MIS-C. MIS-C is a rare but potentially life-threatening occurrence that arises during or soon after being infected by COVID-19.

Credit: Wochit News    Duration: 00:39Published
Oregon State Troopers Engage In Civil Disobedience, Give Barista Civics Lesson [Video]

Oregon State Troopers Engage In Civil Disobedience, Give Barista Civics Lesson

At a time when US police officers are under extraordinarily close scrutiny, a crowd of Oregon state troopers failed en masse. Gizmodo reports the trio came into a coffee shop not wearing masks, despite Oregon Gov. Kate Brown having mandated them that very day. When the store’s assistant manager told the troopers masks were required if they wanted to order something, they refused on the ground of civil liberties. Governor Brown has no authority to take our civil liberties.

Credit: Wochit News    Duration: 00:40Published
Despite Dire Condition Of Great Barrier Reef, Things Are Far Better Far Below [Video]

Despite Dire Condition Of Great Barrier Reef, Things Are Far Better Far Below

The novel coronavirus COVID-19 pandemic has thrown a wrench into scientific research worldwide. However, the Schmidt Ocean Institute has managed to hang on, and has presented some interesting findings. According to Gizmodo, warm waters have led to record coral bleaching this year and could hasten the reef’s die-off. But while surface corals are suffering, nearly a mile beneath the surface, deep-sea corals near the Great Barrier Reef are thriving.

Credit: Wochit News    Duration: 00:46Published
Seattle Demanded Essential Workers Get Hazard Pay. So Instacart Sued. [Video]

Seattle Demanded Essential Workers Get Hazard Pay. So Instacart Sued.

The City of Seattle recently imposed 'premium pay' regulations for gig workers delivering groceries during the ongoing pandemic. Now, the city is being sued by Instacart, as well as the Washington Food Industry Association, a local grocery advocacy group. According to Gizmodo, many companies have been unwilling to provide hazard pay for essential employees during this health crisis. Furthermore, many that did have rescinded or obfuscated those increases.

Credit: Wochit News    Duration: 00:38Published
Study Reveals The Best Fabric For Homemade COVID-19 Masks [Video]

Study Reveals The Best Fabric For Homemade COVID-19 Masks

A study from the US government reports common materials such as cotton can effectively filter particles as small as the coronavirus. According to Gizmodo, the effect is particularly magnified when the cotton cloth is layered, and when the cloth is of a thicker texture, like flannel. The findings offer more evidence that homemade masks can slow the spread of the novel coronavirus COVID-19 and also protect the wearer.

Credit: Wochit News    Duration: 00:35Published

You Might Like


Tweets about this


Related videos from verified sources

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient [Video]

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient

Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.

Credit: Geo Beats     Duration: 00:45Published